WinstonWınston
Cirtran logo

Cirtran

CIRX
33
Food Distribution · Consumer Defensive
Price
$0.03
+0.01 (+32.16%)
Market Cap
$148,363
Winston Score
33
Winston is serious
Below-average fundamentals — multiple weak pillars.

Share count rising — dilution

+1.1% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 4.9M (2021) → 4.9M (2025)

CirTran Corporation is a small U.S. company that has operated across several different businesses over the years, including electronics manufacturing services and consumer products. It has sold goods through retail and direct-to-consumer channels, targeting everyday shoppers rather than large industrial clients. The company has gone through significant changes in its business focus and has a limited operating history in its current form.

CirTran generates revenue by selling products directly and through distribution partners, though its revenue base remains very small. It operates primarily in the United States and carries a market capitalization so low it is considered a micro-cap or nano-cap stock, which means it trades with very little liquidity and limited analyst coverage. The company's operating margin is slightly negative, meaning it spends more to run the business than it earns, and the main risk it faces is sustaining enough revenue and cash flow to remain a going concern over the long term.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+827.9% YoY

YoY Growth Rate

Revenue accelerating

EPS Growth

+155.1% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$0/ year

0.0% of revenue

Below sector average (2%)

Research and development spending

Insider Activity

4.8%ownership

Flat

Insiders holding steady — not selling despite ability to

Cash Runway

~0 months

$9,589 cash & investments

Quarterly Free Cash Flow

→ Burn rate stable

Short runway — potential dilution ahead through share issuance

Revenue accelerating

Cirtran grew revenue 828% year-over-year and the growth rate is speeding up. That's the kind of momentum growth investors look for — the question is whether margins can follow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
49.2%
Healthy — 49.2% gross margin
Operating Margin
13.3%
Healthy — 13.3% operating margin
ROCE
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
+141.1%
Fast-growing sales (141.1% YoY)
EPS YoY
N/A
Data not available
EPS Consistency
2/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
N/A
Data not available
FCF Margin
-42.8%
Burning cash (-42.8%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
N/A
Data not available
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
0.1x
Attractive valuation — P/E 0.1

P/E under 10. The price tag is small relative to last year's profit.

P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial